Effect of ethanol on lipid metabolism

被引:302
作者
You, Min [1 ]
Arteel, Gavin E. [2 ,3 ]
机构
[1] Northeast Ohio Med Univ, Dept Pharmaceut Sci, Coll Pharm, Rootstown, OH 44272 USA
[2] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
[3] Univ Pittsburgh, Pittsburgh Liver Res Ctr, Pittsburgh, PA 15260 USA
关键词
Alcohol-related liver disease; Steatosis; Lipid homeostasis; Metabolism; ALCOHOLIC FATTY LIVER; HEPATOCYTE GROWTH-FACTOR; ELEMENT-BINDING PROTEIN; TRIGLYCERIDE TRANSFER PROTEIN; ACTIVATED RECEPTOR-GAMMA; NECROSIS-FACTOR-ALPHA; INDUCED HEPATIC STEATOSIS; ACETYL-COA CARBOXYLASE; DE-NOVO LIPOGENESIS; ISOLATED RAT-LIVER;
D O I
10.1016/j.jhep.2018.10.037
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Hepatic lipid metabolism is a series of complex processes that control influx and efflux of not only hepatic lipid pools, but also organismal pools. Lipid homeostasis is usually tightly controlled by expression, substrate supply, oxidation and secretion that keep hepatic lipid pools relatively constant. However, perturbations of any of these processes can lead to lipid accumulation in the liver. Although it is thought that these responses are hepatic arms of the 'thrifty genome', they are maladaptive in the context of chronic fatty liver diseases. Ethanol is likely unique among toxins, in that it perturbs almost all aspects of hepatic lipid metabolism. This complex response is due in part to the large metabolic demand placed on the organ by alcohol metabolism, but also appears to involve more nuanced changes in expression and substrate supply. The net effect is that steatosis is a rapid response to alcohol abuse. Although transient steatosis is largely an inert pathology, the chronicity of alcohol-related liver disease seems to require steatosis. Better and more specific understanding of the mechanisms by which alcohol causes steatosis may therefore translate into targeted therapies to treat alcohol-related liver disease and/or prevent its progression. (C) 2018 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.
引用
收藏
页码:237 / 248
页数:12
相关论文
共 182 条
[1]
Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury [J].
Ambade, Aditya ;
Catalano, Donna ;
Lim, Arlene ;
Kopoyan, Andre ;
Shaffer, Scott A. ;
Mandrekar, Pranoti .
JOURNAL OF HEPATOLOGY, 2014, 61 (04) :903-911
[2]
Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα) [J].
Aoyama, T ;
Peters, JM ;
Iritani, N ;
Nakajima, T ;
Furihata, K ;
Hashimoto, T ;
Gonzalez, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5678-5684
[3]
Crosstalk between Components of Circadian and Metabolic Cycles in Mammals [J].
Asher, Gad ;
Schibler, Ueli .
CELL METABOLISM, 2011, 13 (02) :125-137
[4]
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy [J].
Asimakopoulou, Anastasia ;
Weiskirchen, Sabine ;
Weiskirchen, Ralf .
FRONTIERS IN PHYSIOLOGY, 2016, 7
[5]
UPTAKE OF PLASMA FREE FATTY ACIDS BY ISOLATED RAT LIVER - EFFECT OF GLUCAGON [J].
AYDIN, A ;
SOKAL, JE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1963, 205 (04) :667-&
[6]
Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states [J].
Barrows, BR ;
Parks, EJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04) :1446-1452
[7]
Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1 [J].
Bergheim, Ina ;
Guo, Luping ;
Davis, Molly Anne ;
Lambert, Jason C. ;
Beier, Juliane I. ;
Duveau, Ilinca ;
Luyendyk, James P. ;
Roth, Robert A. ;
Arteel, Gavin E. .
GASTROENTEROLOGY, 2006, 130 (07) :2099-2112
[8]
Berk Paul D, 2005, Trans Am Clin Climatol Assoc, V116, P335
[9]
IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[10]
SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1 [J].
Bouras, T ;
Fu, MF ;
Sauve, AA ;
Wang, F ;
Quong, AA ;
Perkins, ND ;
Hay, RT ;
Gu, W ;
Pestell, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (11) :10264-10276